U.S. Supreme Court Hikma Pharmaceuticals v. Amarin Pharma, Case No. 24-889
U.S. Supreme Court Hikma Pharmaceuticals v. Amarin Pharma, Case No. 24-889  
Podcast: Audio Arguendo
Published On: Wed Apr 29 2026
Description: Administrative Law: When a generic drug label fully carves out a patented use, are allegations that the generic drugmaker calls its product a "generic version" and cites public information about the branded drug enough to plead induced infringement of the patented use? - Argued: Wed, 29 Apr 2026 13:44:54 EDT